Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | TEM | ISRG |
|---|---|---|
| Price | $77.87 | $402.68 |
| Change today | ▼ 4.93% | ▼ 0.97% |
| Market cap | $14.05B | $142.26B |
| Return, 3 months | +26.4% | +0.1% |
| Return, year to date | +31.9% | -28.9% |
| Return, 1 year | -11.5% | -8.1% |
| P/E (TTM) | -54.1 | 46.2 |
| P/B | 31.6 | 7.8 |
| P/E percentile vs own 5y | 19th | 3rd |
| Dividend yield | – | – |
| Revenue growth (YoY, latest qtr) | +21.6% | +18.5% |
| Net profit growth (YoY) | +113.2% | +23.9% |
| Gross margin | 64.0% | 66.7% |
| Operating margin | -19.8% | 31.3% |
| Net margin | -17.8% | 28.4% |
| Return on equity | -67.4% | 17.4% |
| Analyst target vs. price | -11.6% | +21.7% |
| Analyst buy share | 67% | 86% |
| RSI (14) | 66 | 62 |
| 30-day volatility | 102.5% | 31.3% |
| Max drawdown, 1 year | -59.8% | -44.0% |
| Trend read | Strong uptrend | Leaning bullish |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
